Tripartite Motif Containing 71 Suppresses Tumor Growth by Down-Regulating EIF5A2 Expression in Laryngeal Squamous Cell Carcinoma

Overview

Journal Appl Biochem Biotechnol

Specialties Biochemistry
Biotechnology

Date 2024 Nov 23

PMID 39579322

Authors

Dan Lou

Jianxing Wang

Haizhong Zhang

Qiaojing Jia

Lisha Liu

Yanrui Bian

Yue Di

Chunguang Shan

Affiliations

Soon will be listed here.

Abstract

The incidence of laryngeal squamous cell carcinoma (LSCC) has been rising recently. LSCC is one of the most prevalent malignant tumors of the head and neck. In this study, we aimed to investigate whether tripartite motif containing 71 (TRIM71) could serve as a molecular target for the treatment of LSCC. The mRNA and protein levels were examined by using real-time qPCR and Western blot, respectively. Cell proliferation was determined by cell-counting kit 8 assay. To further confirm the function of TRIM71 in LSCC, an in vivo cell line-derived xenograft study was conducted. The half-life of eukaryotic translation initiation factor 5A2 (eIF5A2) protein was measured by cycloheximide chase assay. Our results showed that TRIM71 was significantly downregulated in LSCC tumor tissues. TRIM71 overexpression significantly inhibited LSCC cell growth and suppressed tumor volume and weight in the xenograft models. The interaction between TRIM71 and eIF5A2 was verified by co-immunoprecipitation assay. Moreover, overexpression of TRIM71 in LSCC cells significantly inhibited the protein expression of eIF5A2 by down-regulating its stability, while it did not affect its mRNA level. In contrast, overexpression of eIF5A2 abolished the anti-tumor effects of TRIM71. In summary, TRIM71 may exert its anti-tumor effects through regulating eIF5A2, highlighting the potential of TRIM71 as an effective therapeutic target for the treatment of LSCC.

References

Fasunla A, Ogundoyin O, Onakoya P, Nwaorgu O . Malignant tumors of the larynx: Clinicopathologic profile and implication for late disease presentation. Niger Med J. 2016; 57(5):280-285. PMC: 5036299. DOI: 10.4103/0300-1652.190596. View

Li M, Zhao S, Eskander A, Rygalski C, Brock G, Parikh A . Stage Migration and Survival Trends in Laryngeal Cancer. Ann Surg Oncol. 2021; 28(12):7300-7309. PMC: 9013009. DOI: 10.1245/s10434-021-10318-1. View

Connacher R, Goldstrohm A . Molecular and biological functions of TRIM-NHL RNA-binding proteins. Wiley Interdiscip Rev RNA. 2020; 12(2):e1620. PMC: 7855385. DOI: 10.1002/wrna.1620. View

Torres-Fernandez L, Jux B, Bille M, Port Y, Schneider K, Geyer M . The mRNA repressor TRIM71 cooperates with Nonsense-Mediated Decay factors to destabilize the mRNA of CDKN1A/p21. Nucleic Acids Res. 2019; 47(22):11861-11879. PMC: 7145526. DOI: 10.1093/nar/gkz1057. View

Chen Y, Yuan R, Yang W, Hsu H, Jeng Y . The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing. J Pathol. 2012; 229(3):486-96. DOI: 10.1002/path.4130. View

Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl E, Nitsch R . A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol. 2008; 10(8):987-93. DOI: 10.1038/ncb1759. View

Yin J, Kim T, Park N, Shin D, Choi H, Cho S . TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling. Oncotarget. 2016; 7(48):79854-79868. PMC: 5346756. DOI: 10.18632/oncotarget.13036. View

Ning L, Wang L, Zhang H, Jiao X, Chen D . Eukaryotic translation initiation factor 5A in the pathogenesis of cancers. Oncol Lett. 2020; 20(4):81. PMC: 7436936. DOI: 10.3892/ol.2020.11942. View

Wei J, Cao J, Zhang D, Liao B, Zhong W, Lu J . EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo. Br J Cancer. 2014; 110(7):1767-77. PMC: 3974079. DOI: 10.1038/bjc.2014.52. View

10.

Tang D, Dong S, Ma N, Xie D, Chen L, Fu L . Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology. 2010; 51(4):1255-63. DOI: 10.1002/hep.23451. View

11.

Zhu W, Cai M, Tong Z, Dong S, Mai S, Liao Y . Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut. 2011; 61(4):562-75. DOI: 10.1136/gutjnl-2011-300207. View

12.

Huang P, Zeng T, Ban X, Li M, Zhang B, Zhu Y . Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy. BMC Cancer. 2016; 16:669. PMC: 4994420. DOI: 10.1186/s12885-016-2714-2. View

13.

Fang L, Gao L, Xie L, Xiao G . GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells. Oncol Rep. 2017; 39(3):1283-1291. DOI: 10.3892/or.2017.6161. View

14.

Wu Z, Yue J, Zhou T, Xiao H . Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma. Biofactors. 2021; 47(3):478-488. DOI: 10.1002/biof.1722. View

15.

Mitschka S, Ulas T, Goller T, Schneider K, Egert A, Mertens J . Co-existence of intact stemness and priming of neural differentiation programs in mES cells lacking Trim71. Sci Rep. 2015; 5:11126. PMC: 4460895. DOI: 10.1038/srep11126. View

16.

Torres Fernandez L, Mitschka S, Ulas T, Weise S, Dahm K, Becker M . The stem cell-specific protein TRIM71 inhibits maturation and activity of the pro-differentiation miRNA let-7 via two independent molecular mechanisms. RNA. 2021; . PMC: 8208056. DOI: 10.1261/rna.078696.121. View

17.

Chang H, Martinez N, Thornton J, Hagan J, Nguyen K, Gregory R . Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem cell proliferation. Nat Commun. 2012; 3:923. PMC: 3518406. DOI: 10.1038/ncomms1909. View

18.

Liu Q, Novak M, Pepin R, Maschhoff K, Hu W . Different congenital hydrocephalus-associated mutations in Trim71 impair stem cell differentiation via distinct gain-of-function mechanisms. PLoS Biol. 2023; 21(2):e3001947. PMC: 9910693. DOI: 10.1371/journal.pbio.3001947. View

19.

Xu G, Shi X, Sun L, Zhou Q, Zheng D, Shi H . Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells. J Zhejiang Univ Sci B. 2013; 14(6):460-7. PMC: 3682161. DOI: 10.1631/jzus.B1200200. View

20.

Clement P, Johansson H, Wolff E, Park M . Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J. 2006; 273(6):1102-14. PMC: 4406228. DOI: 10.1111/j.1742-4658.2006.05135.x. View